Discontinued — last reported Q3 '19
An increase indicates that the segment's specific intangible assets have lost value, potentially signaling poor acquisition performance or declining market relevance of proprietary technologies. A decrease or zero value suggests stable asset valuations and successful management of the segment's intellectual property.
This metric represents the non-cash charge recognized when the carrying value of identifiable intangible assets, such as...
Peers in the medical device and life sciences sectors report similar charges under 'Impairment of Intangible Assets,' often triggered by regulatory hurdles or competitive disruption in specialized product lines.
bdx_segment_interventional_impairment_of_intangible_assets_excluding_goodwill